12/19
11:17 am
fold
Amicus Therapeutics (NASDAQ:FOLD) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
12/19
10:58 am
fold
Shareholder Alert: The Ademi Firm investigates whether Amicus Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
Low
Report
Shareholder Alert: The Ademi Firm investigates whether Amicus Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
12/19
10:34 am
fold
Amicus Therapeutics (NASDAQ:FOLD) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $14.50 price target on the stock, down previously from $21.00.
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $14.50 price target on the stock, down previously from $21.00.
12/19
09:26 am
fold
FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders
Low
Report
FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders
12/17
09:12 am
fold
Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $17.00 price target on the stock.
12/15
02:14 am
fold
DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT [Yahoo! Finance]
Low
Report
DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT [Yahoo! Finance]
12/13
07:35 pm
fold
Why Amicus Therapeutics (FOLD) Is Up 6.6% After Bullish Analyst Upgrades On Earnings Outlook [Yahoo! Finance]
Low
Report
Why Amicus Therapeutics (FOLD) Is Up 6.6% After Bullish Analyst Upgrades On Earnings Outlook [Yahoo! Finance]
12/13
07:15 am
fold
Amicus Therapeutics (FOLD) Soars to 52-Week High on ‘Strong Buy' Reco [Yahoo! Finance]
Low
Report
Amicus Therapeutics (FOLD) Soars to 52-Week High on ‘Strong Buy' Reco [Yahoo! Finance]
11/28
10:23 pm
fold
Assessing Amicus Therapeutics (FOLD) Valuation as Shares Gain 11% Over Past Month [Yahoo! Finance]
Low
Report
Assessing Amicus Therapeutics (FOLD) Valuation as Shares Gain 11% Over Past Month [Yahoo! Finance]
11/28
08:31 am
fold
How Strong Galafold and Pombiliti Sales Helped Amicus Therapeutics (FOLD) Surpass Expectations and Shift Its Outlook [Yahoo! Finance]
Low
Report
How Strong Galafold and Pombiliti Sales Helped Amicus Therapeutics (FOLD) Surpass Expectations and Shift Its Outlook [Yahoo! Finance]
11/26
02:01 pm
fold
Amicus Therapeutics (NASDAQ:FOLD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/14
01:10 pm
fold
Amicus Therapeutics (NASDAQ:FOLD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/11
04:59 pm
fold
Amicus Therapeutics: Moving Towards Consistent Profitability [Seeking Alpha]
Low
Report
Amicus Therapeutics: Moving Towards Consistent Profitability [Seeking Alpha]
11/10
03:40 am
fold
A Look at Amicus Therapeutics's (FOLD) Valuation After Q3 Profitability and Rare Disease Therapy Growth [Yahoo! Finance]
Medium
Report
A Look at Amicus Therapeutics's (FOLD) Valuation After Q3 Profitability and Rare Disease Therapy Growth [Yahoo! Finance]
11/10
03:01 am
fold
Zacks.com featured highlights include EverQuote, Amicus, Lam Research and Cboe Global Markets EverQuote, Amicus, Lam Research and Cboe Global Markets [Yahoo! Finance]
Medium
Report
Zacks.com featured highlights include EverQuote, Amicus, Lam Research and Cboe Global Markets EverQuote, Amicus, Lam Research and Cboe Global Markets [Yahoo! Finance]
11/6
04:27 pm
fold
Amicus Therapeutics (NASDAQ:FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $18.00 to $19.00. They now have an "overweight" rating on the stock.
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $18.00 to $19.00. They now have an "overweight" rating on the stock.
11/5
12:25 pm
fold
Amicus Therapeutics (NASDAQ:FOLD) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $9.00 to $11.00. They now have a "neutral" rating on the stock.
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $9.00 to $11.00. They now have a "neutral" rating on the stock.
11/4
07:00 am
fold
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates
Low
Report
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates
10/31
07:00 am
fold
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
Low
Report
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
10/26
01:08 am
fold
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at
Wall Stree
Low
Report
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at
Wall Stree
10/25
11:32 pm
fold
Assessing Amicus Therapeutics After a 7.8% Rally and Growing Pipeline Optimism [Yahoo! Finance]
Low
Report
Assessing Amicus Therapeutics After a 7.8% Rally and Growing Pipeline Optimism [Yahoo! Finance]
10/25
01:34 pm
fold
A Fresh Look at Amicus Therapeutics (FOLD) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Fresh Look at Amicus Therapeutics (FOLD) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
10/23
07:00 am
fold
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025
Low
Report
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025
10/8
01:09 am
fold
What Does Wall Street Think About Amicus Therapeutics (FOLD)? [Yahoo! Finance]
Medium
Report
What Does Wall Street Think About Amicus Therapeutics (FOLD)? [Yahoo! Finance]
10/7
10:11 am
fold
How the Narrative Around Amicus Therapeutics Is Shifting Amid Legal and Pipeline Developments [Yahoo! Finance]
Low
Report
How the Narrative Around Amicus Therapeutics Is Shifting Amid Legal and Pipeline Developments [Yahoo! Finance]